TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16935609

Group type: COMPARATOR
Intervention: 25-gauge vitrectomy
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: 20-gauge vitrectomy
Number of subjects: 67
Study: 12969097

Group type: EXPERIMENTAL
Intervention: Ephedrine (E) 70 micro g kg‐1
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Esmolol (Es) 500 micro g kg‐1
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 33
Study: 10718887

Group type: EXPERIMENTAL
Intervention: Intervention group (structured feedback programme)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study: 8667172

Group type: EXPERIMENTAL
Intervention: Rejection-sensitive individuals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rejection-sensitive men's jealousy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rejection-sensitive women's hostility and diminished supportiveness
Number of subjects: 0
Study: 1399560

Group type: EXPERIMENTAL
Intervention: 10mg of flunarizine per day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3mg of flunarizine per day
Number of subjects: 40
Study: 6379789

Group type: EXPERIMENTAL
Intervention: Fenoterol (200 μg) administered by pressurized aerosol
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fenoterol (200 μg) administered in powder form
Number of subjects: 14

Group type: COMPARATOR
Intervention: Overall evaluation of both formulations
Number of subjects: 14
Study: 30798790

Group type: EXPERIMENTAL
Intervention: Three-level stepped care intervention
Number of subjects: 0
Study: 29564773

Group type: EXPERIMENTAL
Intervention: 3D robotic system with error-augmenting forces
Number of subjects: 41

Group type: COMPARATOR
Intervention: Null-field conditions (control group)
Number of subjects: 41
Study: 27001281

Group type: EXPERIMENTAL
Intervention: Test breakfast (lower carbohydrate, higher fat and protein content)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference breakfast (traditional breakfast)
Number of subjects: 20
Study: 25494175

Group type: EXPERIMENTAL
Intervention: Soccer
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Zumba
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control
Number of subjects: 107
Study: 22286927

Group type: EXPERIMENTAL
Intervention: Low-dose CT screening
Number of subjects: 4104

Group type: COMPARATOR
Intervention: No screening (control)
Number of subjects: 4104
Study: 20942920

Group type: EXPERIMENTAL
Intervention: Dynamic feedback intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual feedback on task performance
Number of subjects: 0
Study: 17344602

Group type: EXPERIMENTAL
Intervention: End-tidal isoflurane concentration 0.6 MAC (Group I1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: End-tidal isoflurane concentration 1.0 MAC (Group I2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Endotracheal intubation stimulation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Skin incision and exploration stimulation
Number of subjects: 40
Study: 15685517

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 11515717

Group type: EXPERIMENTAL
Intervention: 250 mg tablet of aqueous extract of Uncaria tomentosa (C‐Med‐100)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 350 mg tablet of aqueous extract of Uncaria tomentosa (C‐Med‐100)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-supplemented controls
Number of subjects: 12
Study: 9721000

Group type: EXPERIMENTAL
Intervention: Unilateral arm or leg training
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Bilateral arm or leg training
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Untrained limbs (unilateral training)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Untrained limbs (bilateral training)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Bilateral index (BI) in trained limbs of bilateral training group
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Bilateral index (BI) in trained limbs of unilateral training group
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Bilateral index (BI) in untrained limbs of unilateral training group
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Bilateral index (BI) in untrained limbs of bilateral training group
Number of subjects: 39
Study: 7838462

Group type: EXPERIMENTAL
Intervention: Mantle field radiotherapy
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 0.4% stannous fluoride 'brush-in' technique
Number of subjects: 71

Group type: COMPARATOR
Intervention: Preradiotherapy group
Number of subjects: 71
Study: 3421258

Group type: EXPERIMENTAL
Intervention: Preterm labor education, frequent (5 days/week) telephone contact, and self‐palpation of uterine activity (group EP)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Preterm labor education, daily telephone contact, and the Term Guard ambulatory uterine activity monitor (group EM)
Number of subjects: 266

Group type: COMPARATOR
Intervention: All subjects enrolled in year 1
Number of subjects: 266

Group type: COMPARATOR
Intervention: All subjects enrolled in year 2
Number of subjects: 266
Study: 29981817

Group type: EXPERIMENTAL
Intervention: Umbilical cord milking
Number of subjects: 60

Group type: COMPARATOR
Intervention: No milking
Number of subjects: 60
Study: 28846600

Group type: EXPERIMENTAL
Intervention: LTLT-cooked roast, 58 °C, 72 min
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: LTLT-cooked roast, 58 °C, 17 h
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Oven-cooked roast, 160 °C
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: LTLT-cooked minced patties, 58 °C, 17 h
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: LTLT cooking for 72 min
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: LTLT cooking for 17 h
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Oven cooking
Number of subjects: 37
Study: 25510746

Group type: EXPERIMENTAL
Intervention: Pitavastatin 2 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pravastatin 20 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: SES with LDL cholesterol < 70 mg/dL
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: BES
Number of subjects: 60
Study: 23186613

Group type: EXPERIMENTAL
Intervention: High-dose-rate intraluminal brachytherapy (ILBT) through percutaneous transhepatic biliary drainage (PTBD)
Number of subjects: 18
Study: 21036778

Group type: EXPERIMENTAL
Intervention: BNP-guided diagnostic strategy
Number of subjects: 314

Group type: COMPARATOR
Intervention: Standard diagnostic strategy
Number of subjects: 314
Study: 19044214

Group type: EXPERIMENTAL
Intervention: Venlafaxine IR 150 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 17699248

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (1 g total, divided into 300 mg over 1.5 h on days 1 and 15, and 400 mg over 2.5 h on day 29)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control (no supplemental iron)
Number of subjects: 96
Study: 12828803

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT) for depression
Number of subjects: 58
Study: 10554841

Group type: EXPERIMENTAL
Intervention: Tight fundoplication (group A)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal fundoplication (group B)
Number of subjects: 16
Study: 8764308

Group type: EXPERIMENTAL
Intervention: Sucrose polyester (SPE) - 52 g of fat replaced, 3.1 MJ, 740 kcal
Number of subjects: 95

Group type: COMPARATOR
Intervention: Normal dietary fat - 5.0 MJ, 1,195 kcal
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Sucrose polyester (SPE)
Number of subjects: 95
Study: 1865045

Group type: EXPERIMENTAL
Intervention: Methylphenidate (35.33 mg/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 6345421

Group type: EXPERIMENTAL
Intervention: Triiodothyronine supplementation (50 micrograms, 3 times daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (Gp B)
Number of subjects: 18
Study: 31209630

Group type: EXPERIMENTAL
Intervention: Scrambler Therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: TENS
Number of subjects: 50
Study: 28409566

Group type: EXPERIMENTAL
Intervention: Combined administration of yohimbine (α2-adrenergic antagonist) and hydrocortisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrocortisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Yohimbine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27336209

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Combination of Letrozole and Berberine
Number of subjects: 644

Group type: COMPARATOR
Intervention: Berberine
Number of subjects: 644
Study: 24942888

Group type: EXPERIMENTAL
Intervention: NDC intervention areas
Number of subjects: 0

Group type: COMPARATOR
Intervention: HSE high deprivation areas
Number of subjects: 0
Study: 22938660

Group type: EXPERIMENTAL
Intervention: SCysCAC formula
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Arnal-Dade formula
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Larsson formula
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Rule formula
Number of subjects: 96
Study: 20865875

Group type: EXPERIMENTAL
Intervention: Automated intermittent bolus (2.5 ml every 15 minutes)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Continuous epidural infusion (10 ml/hour)
Number of subjects: 50
Study: 18441457

Group type: EXPERIMENTAL
Intervention: Betaxolol adding group
Number of subjects: 65

Group type: COMPARATOR
Intervention: Amlodipine dose‐up group
Number of subjects: 65
Study: 15915547

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 12783344

Group type: EXPERIMENTAL
Intervention: HPCP stent
Number of subjects: 100

Group type: COMPARATOR
Intervention: PE stent
Number of subjects: 100
Study: 10606114

Group type: EXPERIMENTAL
Intervention: 60% inspired oxygen concentration
Number of subjects: 16

Group type: COMPARATOR
Intervention: 21% inspired oxygen concentration
Number of subjects: 16
Study: 7813271

Group type: EXPERIMENTAL
Intervention: Pirbuterol
Number of subjects: 26

Group type: COMPARATOR
Intervention: Ipratropium
Number of subjects: 26
Study: 1683340

Group type: EXPERIMENTAL
Intervention: 25 mg zotepine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 50 mg zotepine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 100 mg zotepine
Number of subjects: 15

Group type: COMPARATOR
Intervention: 50 mg clozapin (reference substance)
Number of subjects: 15
Study: 6114503

Group type: EXPERIMENTAL
Intervention: fluphenazine enanthate
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: pipothiazine palmitate IM
Number of subjects: 59

Group type: COMPARATOR
Intervention: therapy responders
Number of subjects: 59

Group type: COMPARATOR
Intervention: therapy non-responders
Number of subjects: 59
Study: 6146272

Group type: EXPERIMENTAL
Intervention: Alfentanil (6 micrograms/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study: 31859791

Group type: EXPERIMENTAL
Intervention: Sublingual zolpidem 5 mg
Number of subjects: 67

Group type: COMPARATOR
Intervention: Oral zolpidem 10 mg
Number of subjects: 67
Study: 29578880

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg + Mirabegron 50 mg (combination 5+50 mg)
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg + Mirabegron 25 mg (combination 5+25 mg)
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Mirabegron 25 mg
Number of subjects: 715

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 715
Study: 27222162

Group type: EXPERIMENTAL
Intervention: Child Health Initiative for Lifelong Eating and Exercise (CHILE) intervention, which included a classroom curriculum, teacher and food service training, family engagement, grocery store participation, and healthcare provider support.
Number of subjects: 1898

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 1898
Study: 23925451

Group type: EXPERIMENTAL
Intervention: D-dimer levels ≥ 0.71 μg/mL on admission
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: D-dimer levels ≥ 1.26 μg/mL at discharge
Number of subjects: 461
Study: 22159967

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel
Number of subjects: 144

Group type: COMPARATOR
Intervention: Bipolar dissection
Number of subjects: 144
Study: 20642660

Group type: EXPERIMENTAL
Intervention: Parental Analgesia Slide
Number of subjects: 160
Study: 18335328

Group type: EXPERIMENTAL
Intervention: Myo-inositol 2 gr. plus folic acid 200 mug every day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Folic acid 200 mug every day
Number of subjects: 20
Study: 16199243

Group type: EXPERIMENTAL
Intervention: RBX 64 mg/d
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: RBX 32 mg/d
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study: 12456132

Group type: EXPERIMENTAL
Intervention: Community Activities intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mammography promotion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual counseling and combined intervention
Number of subjects: 0
Study: 10500005

Group type: EXPERIMENTAL
Intervention: Baclofen (10 mg three times daily for 14 days)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 8961085

Group type: EXPERIMENTAL
Intervention: Ephedrine (50 mg, two doses with a 4‐h interval)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Moclobemide (300 mg b.i.d.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2012398

Group type: EXPERIMENTAL
Intervention: Induced hypertension chemotherapy (IHC) using angiotensin II human in 8 patients.
Number of subjects: 13

Group type: COMPARATOR
Intervention: Conventional chemotherapy in 5 patients (5‐fluorouracil, adriamycin, mitomycin C).
Number of subjects: 13
Study: 6957983

Group type: EXPERIMENTAL
Intervention: Pirenzepine (50 mgs orally)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31299061

Group type: EXPERIMENTAL
Intervention: WALK (3-min moderate-intensity walk every 30-min)
Number of subjects: 11

Group type: COMPARATOR
Intervention: SIT (remained seated for 5 hours)
Number of subjects: 11
Study: 27509544

Group type: EXPERIMENTAL
Intervention: Gadoxetate disodium
Number of subjects: 44

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 44

Group type: COMPARATOR
Intervention: Gadoterate meglumine
Number of subjects: 44
Study: 25583852

Group type: EXPERIMENTAL
Intervention: Sensory integration balance training (experimental group, n = 39)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional rehabilitation (control group, n = 41)
Number of subjects: 80
Study: 23899638

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Risperidone, Olanzapine, Ziprasidone
Number of subjects: 30
Study: 20953579

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Combined training (aerobic + resistance)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Aerobic plus resistance exercise
Number of subjects: 251

Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 251
Study: 19909588

Group type: EXPERIMENTAL
Intervention: GnRH agonist (0.2 mg of triptorelin)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Recombinant HCG (250 microg)
Number of subjects: 100
Study: 17213972

Group type: EXPERIMENTAL
Intervention: Sodium chondroitin sulphate (Uropol S)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Anticholinergic agent (tolterodine)
Number of subjects: 82
Study: 12911553

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 128

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 128
Study: 11760898

Group type: EXPERIMENTAL
Intervention: Transanal endoscopic microsurgery (TEM)
Number of subjects: 33
Study: 9396886

Group type: EXPERIMENTAL
Intervention: Induction with oxytocin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Induction with prostaglandin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Induction with oxytocin or prostaglandin if failed
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Number of digital vaginal examinations > 8
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Number of digital vaginal examinations 7 to 8
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Number of digital vaginal examinations 5 to 6
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Number of digital vaginal examinations 3 to 4
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duration of active labor >= 12 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duration of active labor 9 to < 12 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duration of active labor 6 to < 9 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duration of active labor 2 to < 6 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meconium-stained amniotic fluid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parity of 0
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time from membrane rupture to active labor >= 48 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time from membrane rupture to active labor 24 to < 48 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group B streptococcal colonization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal antibiotics before delivery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cesarean section
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Operative vaginal delivery
Number of subjects: 0
Study: 7895956

Group type: EXPERIMENTAL
Intervention: High-fat meal (1300 kcal)
Number of subjects: 12
Study: 3300348

Group type: EXPERIMENTAL
Intervention: 10 units of oxytocin diluted in physiologic saline solution (20 ml total volume)
Number of subjects: 78

Group type: COMPARATOR
Intervention: 20 ml of saline solution alone (control)
Number of subjects: 78
Study: 31676303

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 0
Study: 31710994

Group type: EXPERIMENTAL
Intervention: Heroin (low, medium, high doses)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Hydromorphone (low, medium, high doses)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 27910134

Group type: EXPERIMENTAL
Intervention: Jacky-Like catheter (JLC)
Number of subjects: 387

Group type: COMPARATOR
Intervention: 2-catheter approach (2C)
Number of subjects: 387
Study: 25321623

Group type: EXPERIMENTAL
Intervention: EVG/COBI/FTC/TDF
Number of subjects: 700

Group type: COMPARATOR
Intervention: EFV/FTC/TDF
Number of subjects: 700
Study: 23291270

Group type: EXPERIMENTAL
Intervention: Smartphone intervention with diaries and therapist feedback
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no smartphone intervention)
Number of subjects: 140
Study: 21802161

Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg/d)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg/d) and Placebo
Number of subjects: 48
Study: 18435210

Group type: EXPERIMENTAL
Intervention: Adson A test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adson B test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Costoclavicular maneuver (CCM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elevated arm stress test (Roos)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supraclavicular pressure (SCP)
Number of subjects: 0
Study: 17323733

Group type: EXPERIMENTAL
Intervention: Implant-supported mandibular overdentures (ISMOs) delivered after 1 week
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional mandibular dentures delivered after 1 week, converted to ISMOs after 3 months
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (ISMOs and conventional dentures)
Number of subjects: 20
Study: 12970728

Group type: EXPERIMENTAL
Intervention: Transrectal ultrasound-guided needle biopsy without anesthesia
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: First core location (Apex biopsy)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: First core location (Base biopsy)
Number of subjects: 131
Study: 10900712

Group type: EXPERIMENTAL
Intervention: Intravenous propranolol (0.92‐1.38 micrograms/kg/min)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Cordanum (1.85‐2.7 micrograms/kg/min)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Clonidine (0.018‐0.037 microgram/kg/min)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Dalargin (0.55‐0.83 microgram/kg/min)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: HBO-100% O2 for 1 h at 1.5 ATA
Number of subjects: 74
Study: 8983567

Group type: EXPERIMENTAL
Intervention: 12-h theophylline (treatment A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 24-h theophylline (treatment B)
Number of subjects: 20
Study: 8258465

Group type: EXPERIMENTAL
Intervention: Sustained release theophylline 300 mg + salbutamol 4 mg (Drug I)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Salbutamol 4 mg + theophylline 300 mg (Drug II)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Salbutamol sustained released (asthalin SA) 8 mg (Drug III)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Salbutamol sustained released (ventorlin CR) 8 mg (Drug IV)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Salbutamol alone
Number of subjects: 30
Study: 3517744

Group type: EXPERIMENTAL
Intervention: Pilocarpine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30895883

Group type: EXPERIMENTAL
Intervention: High Social Interaction (HSI) group
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low Social Interaction (LSI) group
Number of subjects: 10